Antimicrobial Peptide LL-37 Drives Rosacea-Like Skin Inflammation in an NLRP3-Dependent Manner.
Quick Facts
What This Study Found
LL-37 induced significant skin inflammation in mice, which was reduced in Nlrp3-deficient mice.
Key Numbers
How They Did This
The study used in vitro experiments with macrophages and in vivo tests on mice to assess LL-37's effects on inflammation.
Why This Research Matters
Understanding the role of LL-37 in rosacea can help develop targeted therapies for this common skin condition. It highlights the importance of the NLRP3 inflammasome in skin inflammation.
What This Study Doesn't Tell Us
The study primarily used animal models, which may not fully replicate human rosacea. Further research is needed to confirm these findings in humans.
Trust & Context
- Original Title:
- Antimicrobial Peptide LL-37 Drives Rosacea-Like Skin Inflammation in an NLRP3-Dependent Manner.
- Published In:
- The Journal of investigative dermatology, 141(12), 2885-2894.e5 (2021)
- Authors:
- Yoon, Sung-Hyun, Hwang, Inhwa, Lee, Eunju, Cho, Hyo-Joung, Ryu, Ju Hee, Kim, Tae-Gyun, Yu, Je-Wook
- Database ID:
- RPEP-05912
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-05912APA
Yoon, Sung-Hyun; Hwang, Inhwa; Lee, Eunju; Cho, Hyo-Joung; Ryu, Ju Hee; Kim, Tae-Gyun; Yu, Je-Wook. (2021). Antimicrobial Peptide LL-37 Drives Rosacea-Like Skin Inflammation in an NLRP3-Dependent Manner.. The Journal of investigative dermatology, 141(12), 2885-2894.e5. https://doi.org/10.1016/j.jid.2021.02.745
MLA
Yoon, Sung-Hyun, et al. "Antimicrobial Peptide LL-37 Drives Rosacea-Like Skin Inflammation in an NLRP3-Dependent Manner.." The Journal of investigative dermatology, 2021. https://doi.org/10.1016/j.jid.2021.02.745
RethinkPeptides
RethinkPeptides Research Database. "Antimicrobial Peptide LL-37 Drives Rosacea-Like Skin Inflamm..." RPEP-05912. Retrieved from https://rethinkpeptides.com/research/yoon-2021-antimicrobial-peptide-ll37-drives
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.